Glipizide
- Product NDC
- 50436-0141
- 11-digit product format
- 504360141
- Labeler code
- 50436
- Product ID
- 50436-0141_07eb37bc-0fac-4d2c-961f-0efc42d0407e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2002-09-25
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50436-0141-1 | Glipizide | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50436-0141 | GLIPIZIDE TABLET [UNIT DOSE SERVICES] | 2 | Legacy NDC, 1 package rows | 20180929_816d6ef6-c544-44cb-afe1-680dff3a5524.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 50436-0141-1 | 50436014101 | 30 in 1 BOTTLE | Historical |